No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.3x · 10Y median 0.2x · 85th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 17
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2026-05-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2026-08-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2024-07-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2025-05-13.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2026-05-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2026-08-10. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:41:46.789Z. Latest historical point 2024-07-31. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for GEN Restaurant Group, Inc. (GENK) stock was $1.61 as of Oct 5, 2026, 4:00 PM EDT, unchanged from the previous close.
Longer view (total return, dividends reinvested): past 12 months -46.2% · 3-year avg -48.2%/yr
GEN Restaurant Group, Inc. operates restaurants in the United States.
Restaurants · Cerritos, CA
Next Earnings Date
Nov 6, 2026
31 days away
EPS Estimate
-0.04
Revenue Est.
$53.95M
Last Quarter Results
EPS
$-0.06
vs Estimate
$-0.11
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1GENK | $53.07M | $1.61 | +0.00% | -46.17% | N/A | N/A | N/A |
| 2FLL | $49.68M | $1.37 | -1.44% | -54.31% | -34.30% | -2.75% | vs GENK |
| 3MSC | $47.80M | $0.99 | -5.45% | -74.05% | -35.37% | N/A | vs GENK |
| 4GGR | $46.83M | $3.17 | -0.94% | -47.01% | -56.20% | N/A | vs GENK |
| 5HOUR | $64.05M | $1.82 | -2.15% | -35.78% | N/A | N/A | vs GENK |
| 6AHMA | $39.24M | $1.32 | +0.00% | N/A | N/A | N/A | vs GENK |
forward FY estimate
N/A
$55.70M
vs Estimate
$57.20M
Consensus Rating
Based on 1 analyst
Average Price Target
$2.50
+55.3% upside
Low
$2.50
Current
$1.61
High
$2.50
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Quarter ending Dec 2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Quarter ending Mar 2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Quarter ending Jun 2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.32 | $-0.32 | $-0.31 | 1 |
| FY 2027 | $-0.17 | $-0.17 | $-0.17 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $53.79M | $53.95M | $54.11M | 1 |
| Quarter ending Dec 2026 | $51.65M | $51.80M | $51.95M | 1 |
| Quarter ending Mar 2027 | $55.74M | $55.90M | $56.06M | 1 |
| Quarter ending Jun 2027 | $57.13M | $57.30M | $57.47M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $215.56M | $216.90M | $218.24M | 1 |
| FY 2027 | $226.10M | $227.50M | $228.90M | 1 |
